Cargando…
Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting
In 2019, the Lewy Body Dementia Association formed an Industry Advisory Council to bring together a collaborative group of stakeholders with the goal of accelerating clinical research into Lewy body dementia treatments. At the second annual meeting of the Industry Advisory Council, held virtually on...
Autores principales: | Goldman, Jennifer G., Boeve, Bradley F., Armstrong, Melissa J., Galasko, Doug R., Galvin, James E., Irwin, David J., Leverenz, James B., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael C., Keller, Bill, Lai, Robert, Munsie, Leanne, Belleville, Michael, Chaney, Ondrea, Richard, Ian, Taylor, Angela, Graham, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265285/ https://www.ncbi.nlm.nih.gov/pubmed/34238345 http://dx.doi.org/10.1186/s13195-021-00868-7 |
Ejemplares similares
-
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
por: Goldman, Jennifer G., et al.
Publicado: (2020) -
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
por: Sabbagh, Marwan N., et al.
Publicado: (2023) -
Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
por: Biglan, Kevin, et al.
Publicado: (2021) -
Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
por: Battioui, Chakib, et al.
Publicado: (2023) -
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020)